Concepedia

Arin McKinley

AM

7

Publications

1.8K

Citations

7

H-Index

2008

Active since

Affiliations

Portland VA Medical Center(Current)

Oregon Health & Science University

Brigham and Women's Hospital

Dana-Farber Cancer Institute

Harvard University

Arin McKinley is an author at Portland VA Medical Center specializing in drug discovery, systems biology, and tumor biology.

Top concepts

Publications per year

2008–2019

7

Publications

7

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

Michael C. Heinrich, Robert G. Maki, Christopher L. Corless et al. · Journal of Clinical Oncology · 2008 · 799 citations · Full text

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants

Bryan D. Smith, Michael D. Kaufman, Wei-Ping Lu et al. · Cancer Cell · 2019 · 270 citations

, , +9

Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated with Imatinib-Resistant Gastrointestinal Stromal Tumors

Michael C. Heinrich, Diana Griffith, Arin McKinley et al. · Clinical Cancer Research · 2012 · 218 citations

Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases

Michael C. Heinrich, Heikki Joensuu, George D. Demetri et al. · Clinical Cancer Research · 2008 · 212 citations

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

César Serrano, Adrián Mariño‐Enríquez, Derrick L. Tao et al. · British Journal of Cancer · 2019 · 159 citations · Full text

Rows per page

1–5 of 7